# Ethics and Safety Governance Note

> **SAFETY NOTICE:**
> **ADVISORY SYSTEM ONLY — NO AUTOMATIC PRODUCTION ROLLBACK.**
> High-impact actions require explicit confirmation by an authorized human operator.

---

## 1. Executive Summary & Purpose

The **Explainable Healthcare Release Rollback Adviser** is an operational decision-support tool engineered specifically for healthcare Software Operations Center (SOC) analysts and Release Managers. Its purpose is to quantify and explain technical release degradation following software deployments across hospital instances.

This system provides **transparent risk quantification and explainable evidence**; it **does NOT make clinical decisions** and **does NOT autonomously alter, restart, or roll back production hospital software**.

---

## 2. Core Safety & Governance Principles (13 Mandates)

1. **Advisory-Only Architecture:**
   The adviser functions exclusively in an advisory capacity. It generates recommendations (`ROLLBACK RECOMMENDED`, `HUMAN REVIEW`, `CONTINUE`) accompanied by structured evidence. It does not possess direct execution capabilities to shut down, terminate, or revert hospital production containers or databases.

2. **No Automatic Production Rollback:**
   Even when telemetry indicates severe technical degradation or critical risk (risk score ≥ 80), the system will **never** automatically initiate a rollback without direct, interactive human confirmation.

3. **Mandatory Human Confirmation for High-Impact Actions:**
   Any high-impact recommendation (such as `ROLLBACK RECOMMENDED`) triggers an interactive confirmation modal in the user interface. An authorized human operator must physically click `CONFIRM ROLLBACK` to acknowledge and authorize the deployment intervention.

4. **Synthetic Data for Prototype Evaluation:**
   All release records (512 deployments), telemetry traces (latency, error rate, transactions), and hospital tenant identities used in this prototype are **100% synthetic**. No real hospital operational data or actual vendor systems are queried.

5. **Strict Absence of Patient Health Information (PHI):**
   **No real patient data, protected health information (PHI), electronic health records, or patient identifiers are stored, processed, or transmitted by this application.** All simulated telemetry reflects aggregated service metrics (e.g. HTTP 500 error counts, transaction throughput) and synthetic clinical workflow tags (e.g. "Pharmacy dispensing verification").

6. **Not a Clinical Decision Support System (CDSS):**
   This application is strictly an IT and service infrastructure reliability adviser. It is **NOT** a clinical decision support system, diagnostic tool, or medical device under FDA/CE guidelines. Healthcare clinicians must never rely on this dashboard for medical diagnosis, treatment planning, or clinical triage.

7. **Acknowledge Risk Recommendations Can Be Erroneous:**
   Deterministic rules can generate false positives (e.g. transient network blips triggering false rollbacks) or false negatives (e.g. silent application bugs where errors register as HTTP 200). Human operators must remain actively engaged and apply critical engineering judgment.

8. **Impact of Missing or Degraded Telemetry:**
   When monitoring agents fail or telemetry signals are missing (e.g., latency signal offline or unmeasured), the system must **never silently assume the system is safe**. Missing evidence must be flagged explicitly as `"Insufficient Evidence"` and escalate the release to `"HUMAN REVIEW"`.

9. **Human Accountability for Deployment Decisions:**
   Final authority and legal accountability for all software rollback or continuation decisions remain solely with the human operator (SOC Analyst or Release Manager). The adviser serves to inform, not replace, human operational responsibility.

10. **Mandatory Override Justification for Auditability:**
    If a human operator chooses to override the adviser's recommendation (e.g., continuing a release despite a `ROLLBACK RECOMMENDED` advisory), the system strictly enforces a mandatory, non-trivial clinical/operational justification (minimum 10 characters). This explanation is permanently logged in the audit trail.

11. **Strict Role-Based Access Control (RBAC):**
    Risk rule definitions, metric thresholds, and scoring weights (R1–R6) may only be reconfigured by authorized **Release Managers**. Operations Analysts have read-only visibility into rule configurations to prevent unauthorized threshold tampering during active incidents.

12. **Rule Modification Audit Trail:**
    All adjustments to risk rules—including previous thresholds, new thresholds, previous weights, new weights, user identity, role, and UTC timestamps—are immutably captured in the rule-change audit log.

13. **Prerequisites for Future Production Deployment:**
    Transitioning this system from a synthetic engineering prototype to a live healthcare production environment would necessitate comprehensive clinical governance sign-off, HIPAA/GDPR security compliance audits, end-to-end TLS encryption, enterprise SSO/SAML integration, high-availability multi-region databases, and formal institutional review.

---

## 3. Clear Distinction: Technical Release Risk vs. Clinical Decision-Making

It is essential to maintain a rigorous conceptual boundary between **technical release-risk quantification** and **clinical medical decision-making**:

| Dimension | Technical Release-Risk Adviser (This System) | Clinical Decision-Making System (CDSS) |
| :--- | :--- | :--- |
| **Primary Domain** | IT Infrastructure, microservice telemetry, network latency, database connection pools. | Patient care, medication dosage, disease diagnosis, diagnostic imaging. |
| **Primary End Users** | SOC Tier 1/2 Analysts, Site Reliability Engineers, Clinical Release Managers. | Physicians, Nurses, Pharmacists, Radiologists. |
| **Primary Data Inputs** | HTTP status codes, P95 latency ms, transaction count drop %, tenant metadata. | Vital signs, lab test results, patient history, imaging DICOM files, allergies. |
| **Output Type** | Advisory recommendation (`ROLLBACK`, `HUMAN REVIEW`, `CONTINUE`) with signal evidence. | Medical diagnostic recommendations, prescription safety alerts, clinical treatment plans. |
| **Regulatory Category** | Enterprise DevOps / Observability tool. | Class II / Class III Medical Device (FDA 510(k), EU MDR). |
| **Failure Implication** | Unnecessary deployment rollback or delayed software fix deployment. | Adverse patient health outcome or medical misdiagnosis. |

---

## 4. Summary

The Explainable Healthcare Release Rollback Adviser exists to augment human operations engineers with transparent, interpretable telemetry synthesis. By enforcing mandatory human sign-off, strict override accountability, transparent audit logs, and clear operational boundaries, the system ensures that healthcare IT deployments remain reliable without ever displacing human engineering accountability.
